Abstract
One year's experience with phenylketonuria during the calendar year 1966, the first year for compulsory newborn screening in California, was reviewed. The over-all prevalence rate from reported cases in California during this period was one case per 19,500 persons tested. Fifty-seven persons suspected of having pku were evaluated, and 25 of them were determined to be phenylketonuric. Eleven of the 25 were infants in whom the abnormality was detected through the newborn screening program or because it was detected in a sibling through a screening program. All the newborn phenylketonuric patients were developing normally at the time of last report (although the follow-up periods were short).
In nine of the other children, pku was detected because they were retarded. Five retarded children who were diagnosed as phenylketonuric at another clinic were given dietary assistance.
Five additional infants had elevated serum phenylalanines but did not have the classic biochemical findings of pku and are being evaluated further. Nine infants with positive screening tests exhibited biochemical and clinical findings consistent with transient tyrosinemia. Eighteen other children were evaluated and found to have no metabolic abnormality.
The newborn screening program for pku is of decided benefit in early identification of a group of infants who have a high rate of potentially serious metabolic disease. Early identification permits treatment soon enough to prevent mental retardation. Newly identified patients should be evaluated in a medical setting capable of careful pediatric, biochemical and nutritional surveillance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Avery M. E., Clow C. L., Menkes J. H., Ramos A., Scriver C. R., Stern L., Wasserman B. P. Transient tyrosinemia of the newborn: dietary and clinical aspects. Pediatrics. 1967 Mar;39(3):378–384. [PubMed] [Google Scholar]
- Bessman S. P. Legislation and advances in medical knowledge--acceleration or inhibition? J Pediatr. 1966 Aug;69(2):334–338. doi: 10.1016/s0022-3476(66)80350-5. [DOI] [PubMed] [Google Scholar]
- Cunningham G. C. Phenylketonuria. Early detection, diagnosis and treatment. Calif Med. 1966 Jul;105(1):1–7. [PMC free article] [PubMed] [Google Scholar]
- GUTHRIE R., SUSI A. A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963 Sep;32:338–343. [PubMed] [Google Scholar]
- IRW, NOTRICASIN H. R., FLEMING W. BLOOD PHENYLALANINE LEVELS OF NEWBORN INFANTS. A ROUTINE SCREENING PROGRAM FOR THE HOSPITAL NEWBORN NURSERY. Calif Med. 1964 Nov;101:331–333. [PMC free article] [PubMed] [Google Scholar]
- Koch R., Acosta P., Fishler K., Schaeffler G., Wohlers A. Clinical observations on phenylketonuria. Am J Dis Child. 1967 Jan;113(1):6–15. doi: 10.1001/archpedi.1967.02090160056003. [DOI] [PubMed] [Google Scholar]
- Koch R., Williamson M. L., Donnell G. N., Guthrie R., Straus R., Coffelt W., Fish C. H. A cooperative study of two methods for phenylalanine determination: McCaman-Robins fluorimetric and microbiologic inhibition methods. J Pediatr. 1966 Jun;68(6):905–911. doi: 10.1016/s0022-3476(66)80209-3. [DOI] [PubMed] [Google Scholar]
- Rouse B. M. Phenylalanine deficiency syndrome. J Pediatr. 1966 Aug;69(2):246–249. doi: 10.1016/s0022-3476(66)80327-x. [DOI] [PubMed] [Google Scholar]